Top

Reactions Weekly

Published in:

01-03-2023 | Prostate Cancer | Case report

Apalutamide

Various toxicities: 5 case reports

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Barbadillo Villanueva S, et al. APALUTAMIDE AND ENZALUTAMIDE IN METASTATIC HORMONOSENSITIVE PROSTATE CANCER: COMPARISON OF ADVERSE EFFECTS INCIDENCE, TOLERABILITY AND EFFICACY. European Journal of Oncology Pharmacy 6 (Suppl. 1): 21 (plus poster) abstr. P081, Jan 2023. Available from: URL: http://doi.org/10.1097/OP9.0000000000000042 [abstract]

Title: Apalutamide
Various toxicities: 5 case reports
Publication date: 01-03-2023
Publisher: Springer International Publishing
Keywords: Prostate Cancer
Joint Pain
Prostate Cancer
Diarrhea
Hypertension
Diarrhea
Apalutamide
Hypothyroidism
Hypertension
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-35218-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Apalutamide

Various toxicities: 5 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Ganciclovir

Multiple drugs

Isoprenaline/remdesivir/theophylline

Rivaroxaban

Triamcinolone

Antineoplastics